Carregant...
Thrombolytic therapy for pulmonary embolism
BACKGROUND: Thrombolytic therapy is usually reserved for people with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still concern...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2021
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092433/ https://ncbi.nlm.nih.gov/pubmed/33857326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004437.pub6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|